ACR Meeting Abstracts

ACR Meeting Abstracts

Abstracts tagged "classification criteria and serologic tests"

  • Abstract Number: 1154 • ACR/ARHP Annual Meeting 2017

    Use of Including Serum Ferritin and Heme Oxygenase 1 in the Yamaguchi’s Classification for Adult-Onset Still’s Disease: A Multicenter Retrospective Study

    Yohei Kirino1, Yasushi Kawaguchi2, Yoshifumi Tada3, Hiroshi Tsukamoto4, Toshiyuki Ota5, Masahiro Iwamoto6, Hiroki Takahashi7, Kohei Nagasawa8, Syuji Takei9, Takahiko Horiuchi10, Hisae Ichida2, Seiji Minota11, Atsuhisa Ueda1, Akihide Ohta12 and Yoshiaki Ishigatsubo13, 1Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 3Department of Internal Medicine, Division of Rheumatology, Saga University, Saga, Japan, 4Department of medicine and biosystemic science, Kyushu University Hospital, Fukuoka, Japan, 5Department of Rheumatology, Iizuka Hospital, Iizuka, Japan, 6Deivision of Rheumatology and Clinical Immunology, Jichi Medical University, Shimotsuke, Japan, 7Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan, 8Rheumatic Disease Center, Sawara Hospital, Sawara, Japan, 9Pediatrics of Developmental Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, 10Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan, 11Department of Internal Medicine, Division of Rheumatology/Clinical Immunology, Jichi Medical University, Shimotsuke, Japan, 12Saga University School of Medicine, Saga, Japan, 13Yokohama City University, Yokohama, Japan

    Background/Purpose: Yamaguchi’s criteria for classification of adult-onset Still’s disease (AOSD) has been widely applied in clinic despite it was established decades ago. However, hyperferritinemia, which…

  • Abstract Number: 2543 • ACR/ARHP Annual Meeting 2014

    Anti-Ro/SSA Positive Incomplete Sjögren’s Syndrome

    R. Hal Scofield1, Anne Igoe2, Donald U Stone3, Lida Radfar4, Kimberly S. Hefner5, David M. Lewis6, Stephen Young6, Judy Harris7, Kiely Grundahl7, Biji T. Kurien8, Jacen Maier-Moore9, Kristi A. Koelsch10, James Chodosh11, Nelson L. Rhodus12, Raj Gopalakrishnan13, Barbara M. Segal14, A. Darise Farris15, Courtney G. Montgomery16, Christopher J. Lessard17, Kathy L. Sivils18 and Astrid Rasmussen7, 1US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 2Metro Health, Cleveland, OH, 3Dean McGee Eye Institute, Oklahoma City, OK, 4College of Dentristry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Hefner Eye Care and Optical Center, Oklahoma City, OK, 6College of Dentistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 7Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 8U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 9Dept. of Clinical Laboratory Science, University of Texas at El Paso, El Paso, TX, 10Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Okalahoma City, OK, 11Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 12University of Minnesota, Minneapolis, MN, 13Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, 14Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 15Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 16Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 17825 N.E. 13th St., Oklahoma Medical Research Foundation, Oklahoma City, OK, 18Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a systemic disease characterized by dry eyes and mouth resulting from immune mediated damage and dysfunction of the lacrimal and…